PROSCOPE: developing a new optical guided colonoscopy for the earlier detection and better treatment of the second leading cause of cancer deaths in Europe.
Featured News
Read more news.
When detected early, the 5-year survival rate increases dramatically to 90% compared with only 14% for late stage diagnosis.
Today, only 39% of colorectal cancer (CRC) is detected in the early stages. In assisting the growth of early detection of CRC, PROSCOPE will help reduce avoidable deaths.
Partners
Research
News